Format

Send to

Choose Destination
Ann Am Thorac Soc. 2018 Oct;15(10):1131-1136. doi: 10.1513/AnnalsATS.201806-400PP.

Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy.

Author information

1
1 Kaiser Permanente Medical Center, San Diego, California.
2
2 University of Illinois at Chicago, Chicago, Illinois; and.
3
3 University of California San Diego, San Diego, California.

KEYWORDS:

FDA; asthma; biologics; pregnancy; prescribing information

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center